Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GZPHF

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

USD

Set alert

Price alert · GZPHF

All alert types
2.14 USD -0.20 -8.55%
As of Feb 5, 2026
2.14 Day range 2.14
2.14 52-week range 2.64
YTD
0.00%
1 year
-25.69%
Open
2.14
Prev close
2.34
Mkt cap
3.48B
Vol
300
Avg vol
0
EPS
0.26
P/E
8.23
More statistics
Low
2.14
High
2.14

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GZPHF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.25 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 8.2×
FY 2016: 26.6×FY 2017: 14.3×FY 2018: 11.9×FY 2019: 13.0×FY 2020: 9.1×FY 2021: 8.7×FY 2022: 8.2×FY 2023: 8.2×FY 2024: 12.1×FY 2025: 8.2×
FY 2016 5y median 8.2× FY 2025
P/S 0.3×
FY 2016: 2.0×FY 2017: 1.4×FY 2018: 1.0×FY 2019: 0.6×FY 2020: 0.4×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.5×FY 2025: 0.3×
FY 2016 5y median 0.5× FY 2025
P/B 0.6×
FY 2016: 2.3×FY 2017: 1.6×FY 2018: 1.9×FY 2019: 1.7×FY 2020: 1.0×FY 2021: 1.1×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 0.6×
FY 2016 5y median 1.0× FY 2025
P/FCF -25.5×
FY 2016: 18.2×FY 2017: 18.1×FY 2018: 8.7×FY 2019: 15.8×FY 2020: -91.0×FY 2021: 7.3×FY 2022: 5.8×FY 2023: 13.4×FY 2024: 14.8×FY 2025: -25.5×
FY 2016 5y median 7.3× FY 2025
EV/EBITDA 7.6×
FY 2016: 13.6×FY 2017: 6.6×FY 2018: 7.3×FY 2019: 5.9×FY 2020: 3.5×FY 2021: 3.5×FY 2022: 3.4×FY 2023: 3.7×FY 2024: 5.8×FY 2025: 7.6×
FY 2016 5y median 3.7× FY 2025
EV/Sales 0.4×
FY 2016: 1.4×FY 2017: 0.9×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 0.4×
FY 2016 5y median 0.3× FY 2025
FCF Yield -3.9%
FY 2016: 5.5%FY 2017: 5.5%FY 2018: 11.5%FY 2019: 6.3%FY 2020: -1.1%FY 2021: 13.6%FY 2022: 17.3%FY 2023: 7.4%FY 2024: 6.8%FY 2025: -3.9%
FY 2016 5y median 7.4% FY 2025

Profitability

Gross Margin 15.2%
FY 2016: 33.1%FY 2017: 37.7%FY 2018: 23.8%FY 2019: 19.8%FY 2020: 16.9%FY 2021: 19.2%FY 2022: 18.8%FY 2023: 18.8%FY 2024: 16.7%FY 2025: 15.2%
FY 2016 5y median 18.8% FY 2025
Operating Margin 4.0%
FY 2016: 7.3%FY 2017: 11.7%FY 2018: 9.1%FY 2019: 6.2%FY 2020: 6.0%FY 2021: 6.9%FY 2022: 7.2%FY 2023: 6.8%FY 2024: 4.8%FY 2025: 4.0%
FY 2016 5y median 6.8% FY 2025
Net Margin 3.9%
FY 2016: 7.5%FY 2017: 9.8%FY 2018: 8.1%FY 2019: 4.9%FY 2020: 4.7%FY 2021: 5.4%FY 2022: 5.6%FY 2023: 5.4%FY 2024: 3.8%FY 2025: 3.9%
FY 2016 5y median 5.4% FY 2025
ROE 7.7%
FY 2016: 8.7%FY 2017: 10.9%FY 2018: 15.9%FY 2019: 13.2%FY 2020: 11.2%FY 2021: 12.8%FY 2022: 12.4%FY 2023: 11.6%FY 2024: 7.9%FY 2025: 7.7%
FY 2016 5y median 11.6% FY 2025
ROIC 4.0%
FY 2016: 6.4%FY 2017: 10.4%FY 2018: 11.0%FY 2019: 10.1%FY 2020: 7.8%FY 2021: 9.5%FY 2022: 9.1%FY 2023: 8.5%FY 2024: 5.8%FY 2025: 4.0%
FY 2016 5y median 8.5% FY 2025
ROA 3.4%
FY 2016: 5.8%FY 2017: 7.3%FY 2018: 6.7%FY 2019: 5.6%FY 2020: 4.9%FY 2021: 5.6%FY 2022: 5.3%FY 2023: 5.2%FY 2024: 3.5%FY 2025: 3.4%
FY 2016 5y median 5.2% FY 2025

Growth (YoY)

Revenue 0.6%
FY 2016: 4.8%FY 2017: 4.6%FY 2018: 101.6%FY 2019: 53.8%FY 2020: -5.0%FY 2021: 11.9%FY 2022: 2.6%FY 2023: 6.7%FY 2024: -0.7%FY 2025: 0.6%
FY 2016 FY 2025
Operating Income -16.0%
FY 2016: 4.0%FY 2017: 67.8%FY 2018: 55.9%FY 2019: 5.7%FY 2020: -9.4%FY 2021: 30.3%FY 2022: 6.0%FY 2023: 0.9%FY 2024: -29.8%FY 2025: -16.0%
FY 2016 FY 2025
EPS (diluted) 4.6%
FY 2016: 6.9%FY 2017: 17.6%FY 2018: 66.9%FY 2019: -7.5%FY 2020: -8.7%FY 2021: 27.9%FY 2022: 6.6%FY 2023: 2.0%FY 2024: -30.1%FY 2025: 4.6%
FY 2016 FY 2025
Free Cash Flow -141.2%
FY 2016: 55.4%FY 2017: -26.2%FY 2018: 189.5%FY 2019: -44.7%FY 2020: -111.1%FY 2021: 1616.8%FY 2022: 27.1%FY 2023: -55.9%FY 2024: -6.5%FY 2025: -141.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 2.6×FY 2017: 2.6×FY 2018: 1.6×FY 2019: 1.6×FY 2020: 1.6×FY 2021: 1.6×FY 2022: 1.5×FY 2023: 1.5×FY 2024: 1.5×FY 2025: 1.6×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.2×
FY 2016: 2.3×FY 2017: 2.2×FY 2018: 1.3×FY 2019: 1.2×FY 2020: 1.3×FY 2021: 1.3×FY 2022: 1.2×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.5×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 1.5×
FY 2016: -6.5×FY 2017: -4.3×FY 2018: -2.2×FY 2019: -2.3×FY 2020: -2.1×FY 2021: -2.2×FY 2022: -1.8×FY 2023: -1.5×FY 2024: -1.2×FY 2025: 1.5×
FY 2016 5y median -1.5× FY 2025
Interest Coverage 7.3×
FY 2016: 70.9×FY 2017: 346×FY 2018: 16.6×FY 2019: 10.3×FY 2020: 10.1×FY 2021: 11.5×FY 2022: 11.7×FY 2023: 10.9×FY 2024: 8.6×FY 2025: 7.3×
FY 2016 5y median 10.9× FY 2025

Dividends

Dividend Yield 5.2%
FY 2016: 1.3%FY 2017: 1.6%FY 2018: 2.1%FY 2019: 1.7%FY 2020: 3.6%FY 2021: 2.7%FY 2022: 3.4%FY 2023: 4.8%FY 2024: 6.6%FY 2025: 5.2%
FY 2016 5y median 4.8% FY 2025
Payout Ratio 43.6%
FY 2016: 34.0%FY 2017: 22.5%FY 2018: 25.3%FY 2019: 21.6%FY 2020: 32.8%FY 2021: 23.5%FY 2022: 28.2%FY 2023: 39.1%FY 2024: 79.4%FY 2025: 43.6%
FY 2016 5y median 39.1% FY 2025

Annual · latest fiscal year ends 2025-12-31